HCPCS Code S3845

Genetic testing for alpha-thalassemia
Code effective Jul 01, 2003

HCPCS Section
Commercial Payers (Temporary Codes)

S3845 is a valid 2026 HCPCS code meaning Genetic testing for alpha-thalassemia or (Gene test alpha-thalassemia) for short. HCPCS S3845 has been effective since 07/01/2003 and applies to Other medical items or services.

HCPCS Code Details - S3845

HCPCS Level II Code
Section S - Commercial Payers (Temporary Codes)
HCPCS Code S3845
Description

Long description:
Genetic testing for alpha-thalassemia

Short description:
Gene test alpha-thalassemia

HCPCS Pricing indicator 00 - Physician Fee Schedule And Non-Physician Practitioners - Service not separately priced by part B (e.g., services not covered, bundled, used by Part A only, etc.)
Multiple pricing indicator 9 - Not applicable as HCPCS not priced separately by part B or value is not established
Coverage code I - Not payable by Medicare
BETOS2 code Z2 - Undefined codes
HCPCS Action code N - No maintenance for this code
Type of service 9 - Other medical items or services
Effective date Effective Jul 01, 2003
Date added Added Jul 01, 2003

See also

  • HCPCS S3844 · Dna analysis of the connexin 26 gene (gjb2) for susceptibility to congenital, profound deafness

  • HCPCS S3800 · Genetic testing for amyotrophic lateral sclerosis (als)

  • HCPCS S3841 · Genetic testing for retinoblastoma

  • HCPCS S3842 · Genetic testing for von hippel-lindau disease

  • HCPCS S3846 · Genetic testing for hemoglobin e beta-thalassemia

  • HCPCS S3849 · Genetic testing for niemann-pick disease

  • HCPCS S3850 · Genetic testing for sickle cell anemia

  • HCPCS S3853 · Genetic testing for myotonic muscular dystrophy

  • HCPCS S3855 · Genetic testing for detection of mutations in the presenilin - 1 gene

1 Two-digit numeric codes are Level I code modifiers copyrighted© by the American Medical Association's Current Procedural Terminology (CPT).

2 BETOS stands for “Berenson-Eggers Type Of Service”

HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 6/23/2026

CPT® is a registered trademark of the American Medical Association (AMA). All rights reserved.